active
Gabrielle's Angel Foundation for Cancer Research Medical Research Award
Gabrielle’s Angel Foundation funds cutting-edge research in the fields of leukemia, lymphoma, and related cancers of the blood. We support research that focuses on cancer prevention, detection, and treatments that are most likely to be translated into clinical trials within a 3 – 5 year period. The Foundation not only funds mainstream scientific research but also projects that combine integrative (complementary) therapies or botanical agents. These annual Medical Research Awards total $225,000 and are given over a three-year period.
Key Details
Deadline Invalid Date
Award Amount USD 225 000
Duration 3
Eligible Applicant Country United States
Host Country United States
Mobility Rule No
Career Levels
Funding Purpose
Subjects / Fields
Additional Information
Comments Researchers should have been in their positions for less than 5 years.
Our invitation-only grant process is sent out annually each spring to National Cancer Institute (NCI) designated institutions only. Please consult your institution to see if you are eligible to apply. Submissions are due to the Foundation office in August after which they undergo rigorous peer review by the Foundation’s Medical Advisory Board.
This panel of experts, led by Stephen D. Nimer, MD, Director of the Sylvester Comprehensive Cancer Center, selects only the nation’s most promising projects for funding. More than 80% of our grantees go on to obtain further funding thanks to early career support from Gabrielle’s Angel Foundation.
Determinations are made and all applicants notified by the first quarter of the year following application submission, if not sooner.
About the Funder
Gabrielle’s Angel Foundation for Cancer Research United States
Record Information
Last Verified 19 February 2026 by asntech
Last Updated May 2020
Source legacy-import